Actively Recruiting
Double Voiding and Post-transplant UTI
Led by Weill Medical College of Cornell University · Updated on 2025-06-19
438
Participants Needed
1
Research Sites
190 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the risk for blood stream infection and acute rejection of the kidney, Improvements in urinary voiding techniques may reduce the frequency of UTI. The purpose of this study is to evaluate the benefits of "double voiding" in kidney transplant recipients.
CONDITIONS
Official Title
Double Voiding and Post-transplant UTI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult kidney transplant recipients who have routine follow-up at the New York Presbyterian - Weill Cornell Medicine Transplant Clinic
You will not qualify if you...
- Kidney transplant recipients discharged with an indwelling catheter (Foley) after transplant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Weill Cornell Medical College / NY Presbyterian
New York, New York, United States, 10065
Actively Recruiting
Research Team
M
Muthukumar Thangamani, M.D.
CONTACT
A
Ananda Kimm-Drapeau
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here